| P2093 | author name string | Shan He | |
| | Yi Zhang | |
| | Hideo Yagita | |
| | Shin Mineishi | |
| | Yajun Guo | |
| | Fang Xie | |
| | Koji Kato | |
| | Qing Tong | |
| | Izumi Mochizuki | |
| | Kazuhiro Mochizuki | |
| | Yongnian Liu | |
| P2860 | cites work | Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice | Q24288997 |
| | Therapeutic antibody targeting of individual Notch receptors | Q27660544 |
| | Host-reactive CD8+ memory stem cells in graft-versus-host disease | Q28281894 |
| | The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 |
| | Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 |
| | Taking dendritic cells into medicine | Q29619243 |
| | Acute graft-vs-host disease: pathobiology and management | Q33940061 |
| | Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory | Q33946269 |
| | In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection | Q33964570 |
| | Advances in graft-versus-host disease biology and therapy | Q34031916 |
| | Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis | Q34110003 |
| | Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? | Q34149930 |
| | Notch Ligand Delta-Like 4 Regulates Development and Pathogenesis of Allergic Airway Responses by Modulating IL-2 Production and Th2 Immunity | Q34306829 |
| | Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes | Q34522666 |
| | Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13 | Q34541778 |
| | Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. | Q34568892 |
| | Steady-state and inflammatory dendritic-cell development | Q34591334 |
| | Graft-versus-leukemia effects of transplantation and donor lymphocytes | Q34887477 |
| | Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis | Q35175775 |
| | Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease induction | Q35884088 |
| | Regulation of lymphoid development, differentiation, and function by the Notch pathway. | Q36072476 |
| | CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS | Q36229524 |
| | Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs | Q36478455 |
| | Induction of tumor immunity following allogeneic stem cell transplantation | Q36490755 |
| | Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease | Q36505142 |
| | Graft-versus-host disease | Q36793622 |
| | TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4 | Q37036047 |
| | Demystifying the development of dendritic cell subtypes, a little | Q37139265 |
| | The different faces of Notch in T-helper-cell differentiation | Q37376021 |
| | Acute graft-versus-host disease: from the bench to the bedside | Q37420496 |
| | Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. | Q37594746 |
| | Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. | Q37684743 |
| | Deciphering the transcriptional network of the dendritic cell lineage | Q37700905 |
| | Mechanisms regulating dendritic cell specification and development | Q37802420 |
| | Regulatory T cells and IL-17-producing cells in graft-versus-host disease | Q37900645 |
| | Notch and inflammatory T-cell response: new developments and challenges | Q37952793 |
| | Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies | Q37967287 |
| | Notch2 signaling is required for potent antitumor immunity in vivo. | Q39721274 |
| | Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease | Q39737912 |
| | Jagged1 suppresses collagen-induced arthritis by indirectly providing a negative signal in CD8+ T cells. | Q39876476 |
| | Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade | Q39883638 |
| | Suppression of Th2 cell development by Notch ligands Delta1 and Delta4 | Q41962999 |
| | Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells | Q43825047 |
| | APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease | Q44241989 |
| | Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease | Q44925138 |
| | Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. | Q45345853 |
| | Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease | Q45373997 |
| | Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease | Q47371499 |
| | Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells | Q47619638 |
| | Differential regulation of splenic CD8- dendritic cells and marginal zone B cells by Notch ligands. | Q50620064 |
| | Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. | Q50632368 |
| | Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice. | Q50654232 |
| | Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. | Q52002812 |
| | An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin | Q71881409 |
| | Acute graft-versus-host disease does not require alloantigen expression on host epithelium | Q74221421 |
| | Prevention of graft versus host disease by inactivation of host antigen-presenting cells | Q78016071 |
| | Donor APCs are required for maximal GVHD but not for GVL | Q80402910 |
| | Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ | Q80952289 |
| | A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses | Q81357571 |
| | JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis | Q81464305 |
| | Notch signaling in the immune system | Q82881379 |
| | Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells | Q83187973 |
| | Expression of Notch receptors and ligands on immature and mature T cells | Q83396424 |
| | Graft-versus-host disease | Q83468020 |
| | Recipient plasmacytoid DCs are not required to prime allogeneic T-cell responses after BMT | Q84004827 |
| | Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation | Q95816367 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 3772-3782 | |
| P577 | publication date | 2013-02-25 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice | |
| P478 | volume | 190 | |